Pfizer Seeks New Indications Using Biovista Bioinformatics

November 10, 2010Media coverage

By Catherine Shaffer, BioWorld Today Contributing Writer A research collaboration between Pfizer Inc. and Biovista Inc. will seek new indications for Pfizer drug candidates in development using a bioinformatics technology platform developed by Biovista. Terms of the agreement include identification of up to three new indications for each drug. Biovista will receive an undisclosed up-front … Read More

Biovista Announces a Drug Repositioning Collaboration With Pfizer

November 9, 2010Press Releases

CHARLOTTESVILLE, Virginia, November 9, 2010 /PRNewswire/ — Biovista announced today that it has entered into a pilot research collaboration agreement with Pfizer (Pfizer Inc. (NYSE: PFE). The aim of the collaboration is to identify new indications for a number of undisclosed Pfizer development candidates, using Biovista’s Clinical Outcome Search Space (COSS) technology. Under the terms … Read More